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Well-differentiated liposarcoma represents a radiographic diagnostic dilemma. To determine the accuracy, interrater reliability, and
relationship of stranding, nodularity, and size in the MRI differentiation of lipoma and well-differentiated liposarcoma, MRI scans
of 60 patients with large (>5 cm), deep, pathologically proven lipomas or well-differentiated liposarcomas were examined by 10
observers with subspecialty training blinded to diagnosis. Observers indicated whether the amount of stranding, nodularity, and
size of each tumor suggested a benign ormalignant diagnosis and rendered a diagnosis of lipoma orwell-differentiated liposarcoma.
The accuracy, reliability, and relationship of stranding, nodularity, and size to diagnosis were calculated for all samples. 69% of
reader MRI diagnoses agreed with final pathology diagnosis (95% CI 65–73%). Readers tended to err choosing a diagnosis of
liposarcoma, correctly identifying lipomas in 63% of cases (95% CI 58–69%) and liposarcomas in 75% of cases (95% CI 69–80%).
Assessment of the relationship of stranding, nodularity, and size to correct diagnosis showed that the presence of eachwas associated
with a decreased likelihood of a lipoma pathological diagnosis (𝑃 < 0.01). While the radiographic diagnosis of lipoma or well-
differentiated liposarcoma cannot be made with 100% certainty, experienced observers have a 69% chance of rendering a correct
diagnosis.
1. Introduction
Well-differentiated liposarcoma presents a diagnostic
dilemma to the treatment team due to the inaccuracy of
biopsy and the difficulty in differentiating these low-grade
tumors from benign lipomas on imaging alone [1–4]. This
difficulty in diagnosis can lead to patient worry, delays
in diagnosis, and a considerable risk for local recurrence
with inappropriate surgical resection. As well-differentiated
liposarcomas show low to no metastatic potential, with
appropriate excision, low rates of recurrence can be expected
[5–8].
MRI serves as an excellentmodality to discern certain soft
tissue tumors like lipomas given their specific imaging char-
acteristics [1, 3]. Low-grade fatty tumors represent a radio-
graphic spectrum from innocent appearing homogeneous
lesions, isointense to subcutaneous adipose tissue on all
sequences to the more ominous appearing lesions with
heterogeneity (Figures 1 and 2). The ideal treatment situa-
tion for these low-grade fatty tumors would be one where
the pathological diagnosis would correspond perfectly with
the imaging characteristics. However, this pathological to
radiological correlation does not occur in the majority of
cases (Figures 1 and 2) [2, 5, 9]. As such, musculoskeletal
radiologists and orthopaedic oncologists have evolved to
include well-differentiated liposarcoma on the radiographic
differential of suspicious fatty lesions.
Several authors have evaluated the sensitivity and speci-
ficity of specific MRI sequences in the diagnosis of well-
differentiate liposarcoma; however, the diagnostic relia-
bility between specialties (musculoskeletal radiology and
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orthopaedic oncology) has not been well characterized [1–
4, 10]. In addition, specific variables that may portend
an elevated likelihood of well-differentiated liposarcoma
(stranding, nodularity, and size) have been discussed in the
literature extensively, without agreement among the experts
[1–4, 10].
The purpose of this study was therefore to evaluate the
accuracy, reliability, and association between the variables of
size, stranding, and nodularity in the diagnosis of lipoma
versuswell-differentiated liposarcoma based onMRI imaging
alone. In addition, the accuracy and reliability of trainedmus-
culoskeletal radiologists and orthopaedic oncologists in the
radiographic diagnosis of these tumors were assessed to see
if any differences existed between specialties. Our hypothesis
was that experienced readers in both specialties blinded to
diagnosis would be unable to differentiate between a series
of fatty lesions and that the variables of size, nodularity, and
stranding would show no predictive association with these
diagnoses. If true, this study would support the argument
to treat all low-grade fatty lesions with marginal excision
regardless of the MRI interpretation or concern regarding
variables of size, nodularity, or stranding.
2. Materials and Methods
After research ethics board approval,MRI scans of 60 patients
with large (>5 cm in greatest dimension), deep, pathologically
proven lipomas (31 patients) or well-differentiated liposarco-
mas (29 patients) were identified from a prospectively col-
lected database. Pathological review and diagnosis weremade
by one of three pathologists with subspeciality training in
musculoskeletal oncology and sarcoma pathology following
WHO criteria for the classification of sarcoma. Informed
consent was obtained from all research subjects as a part
of their enrolment into this database. Patient MRI scans
were retrospectively examined by 10 observers with subspe-
cialty training in musculoskeletal radiology or orthopaedic
oncology, blinded to diagnosis. There were 2 attending staff
physicians and 3 fellows from each orthopaedic oncology and
musculoskeletal radiology who participated.
After reviewing each patient MRI on a PACS viewing
module, observers indicated whether the amount of strand-
ing, nodularity, and size of each tumor was concerning
for well-differentiated liposarcoma and rendered a diagnosis
of lipoma or well-differentiated liposarcoma. To simulate a
clinical scenario, each reader was given the ability to use
whatever image sequences available for diagnostic purposes
(see later). Stranding (Figure 3) was defined as linear tis-
sue heterogeneity present within the mass, and nodularity
(Figure 4) was defined as intralesional tissue heterogeneity
that was not linear. The concerning size variable was left to
the individual readers discretion for interpretation; however,
all tumors were greater than 5 cm in greatest dimension as
mentioned above. All variables were categorical and recorded
as either “yes” or “no” for the measurements of concerning
size, nodularity, and stranding and whether the reader was
concerned about a diagnosis of well-differentiated liposar-
coma, based on these individual variables. For example,
Figure 1: Axial T1 and T2 MRIs of a patient with a fatty tumor.
Despite the benign appearance of this tumor radiographically, final
pathological review confirmed a diagnosis of low-grade liposar-
coma.
Figure 2: Axial T1 and T2 MRIs of a patient with a large fatty
tumor in the buttock. Despite the large size and intratumoral strand-
ing/nodularity, final pathological review confirmed a diagnosis of
lipoma.
while all lesions were >5 cm, each reader had to indepen-
dently determine whether the size of the lesion, amount of
stranding, or nodularity were concerning for a liposarcoma
diagnosis. Diagnosis categorical variables of “lipoma” or
“well-differentiated liposarcoma” were also recorded for each
tumor.
As the variables of size, stranding, and nodularity are used
clinically by radiologists without standardization criteria to
interpret such images and render a diagnosis, these variables
were intentionally not standardized for individual readers for
the purpose of this study.This was done to simulate a clinical
scenario and therefore better evaluate the ability of readers to
render a correct diagnosis and to determine the reliability and
validity of reader diagnoses towards these tumors.
All imagingwas performedwith 1.5-TMRI system (Signa,
GE Medical System, Milwaukee, WI) using a surface coil
or body coil depending on the anatomic location. Specific
imaging protocols included at least two planes of T1-weighted
images (TR 500ms/TE 10ms) and fast spin echo T2-weighted
images (TR 4800ms/TE 100ms) with selective fat saturation.
STIR sequences (inversion time 110–150msec) were also
occasionally available. In all of the cases reviewed, either T2W
fast spin echo imaging with spectral fat suppression or STIR
imaging was performed. Imaging sequences used by readers
of this study for diagnostic purposes were performed without
contrast agents.
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Figure 3: Axial T1 and T2MRIs showing intralesional stranding in a
fatty tumor. Final pathological review confirmed a diagnosis of low-
grade liposarcoma.
Figure 4: Axial T1 and T2 MRIs showing intralesional nodularity
in a fatty tumor. Final pathological review confirmed a diagnosis of
low-grade liposarcoma.
Kappa statistics along with 95% confidence limits were
used to determine the reliability of each categorical mea-
surement [11]. The interobserver reliability was evaluated by
determining the agreement among the observers.𝑃 values for
comparison to “no agreement” were generated from an exact
test [12]. All 𝑃 values were two-sided and any 𝑃-values less
than 0.05 were considered statistically significant. Sixty MRI
studies resulted in 95% power of 0.8 based on a type I error
of 5%. Data analysis was performed using SAS version 9.2
computer software.
3. Results
3.1. Accuracy. 413/600 (69%) reader diagnoses agreed with
the final pathological diagnosis. The 95% confidence limits
for the accuracy percentagewere (65%–73%). If the pathology
diagnosis was lipoma, readers correctly identified lipoma
in 196/310 (63%) cases (95% CI 58%–69%). If the pathol-
ogy diagnosis was well-differentiated liposarcoma, readers
correctly identified liposarcoma in 217/290 (75%) cases
(95% CI 69%–80%). All readers chose liposarcoma more
frequently than lipoma. There was no difference regarding
diagnostic accuracy when compared between the special-
ties of orthopaedic oncology and musculoskeletal radiology
(average 68%, 95% CI 63%–74% versus 69%, 95% CI 64%–
75%, resp.). Attending physicians had a slightly high rate of
diagnostic accuracy when compared to fellows (average 71%,
95% CI 70%–72% versus 67%, 95% CI 61%–73%, resp.).
Table 1: The interrater reliability for diagnosis and each of the
categorical variables of stranding, nodularity, and size.
Measure Kappa estimate 95% CI Raw proportion ofmatching responses
Diagnosis 0.63 (0.61, 0.65) 0.82
Stranding 0.17 (0.14, 0.19) 0.76
Nodularity 0.41 (0.39, 0.43) 0.72
Size 0.11 (0.09, 0.13) 0.68
Table 2: The relationships of stranding and nodularity to the
diagnosis of liposarcoma.
Stranding Nodularity % Readerliposarcoma % True liposarcoma
Yes Yes 217/228 (95%) 145/228 (64%)
Yes No 95/268 (35%) 108/268 (40%)
No Yes 6/11 (55%) 5/11 (45%)
No No 13/93 (14%) 32/93 (34%)
Table 3: The relationship of concerning size to the diagnosis of
liposarcoma.
Size % Reader liposarcoma % True liposarcoma
Yes 103/138 (75%) 83/138 (60%)
No 228/462 (49%) 207/462 (45%)
3.2. Reliability. Table 1 shows the interrater reliability for
diagnosis and each of the categorical variables of strand-
ing, nodularity, and size. Interrater reliability for diagnosis
showed “substantial” agreement with a kappa estimate of 0.63
(95% CI 0.61–0.65). Interrater reliability showed only “slight”
agreement for stranding and size but “moderate” agreement
for nodularity (kappa estimates 0.17, 0.11, and 0.41; (95% CI
0.14–0.19, 0.09–0.13, 0.39–0.43, resp.).
3.3. Relationship of Stranding, Nodularity, and Size to Diagno-
sis. Tables 2 and 3 show the relationships of stranding, nodu-
larity, and size to the diagnosis of liposarcoma. Positive reader
responses for stranding and nodularity were associated with
an increased likelihood of liposarcoma diagnosis (𝑃 < 0.01).
Although this combination had a higher probability of a true
liposarcoma diagnosis, readers overdiagnosed liposarcoma
by a large margin in this instance. The inverse is true if
readers choose “no” for both stranding and nodularity, which
was associated with a lipoma diagnosis. A positive response
for size was also associated with increased likelihood of a
liposarcoma diagnosis (𝑃 < 0.01), although the misdiagnosis
gap was not as large as for stranding/nodularity, as readers
were overall more likely to choose a diagnosis of liposarcoma.
There was no difference regarding interpretation of these cat-
egorical variables or their relationship towards the ultimate
diagnosis when compared between specialties.
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4. Discussion
Well-differentiated liposarcomas are low-grade fatty tumors
with negligible metastatic potential and less than 10% chance
of local recurrence even after positive margin excision [7,
8, 13]. Well-differentiated liposarcomas do however rep-
resent a diagnostic dilemma given the difficulty discern-
ing well-differentiated liposarcoma from lipoma on imag-
ing and problems associated with sampling error during
biopsy [2]. Due to poor understanding of the biology of
well-differentiated liposarcomas or radiologic phrases like
“liposarcoma cannot be ruled out, referral to orthopaedic
oncologist is recommended,” these tumors are the cause of
unnecessary referral to tertiary sarcoma centers and more
importantly patient worry. As such, a standardized approach
to the radiographic evaluation and treatment of these lesions
would be beneficial to both patients and the physicians who
care for them.
The goal of this study was to determine whether
experienced observers in musculoskeletal radiology and
orthopaedic oncology could differentiate between lipomas
andwell-differentiated liposarcomas on imaging alone and to
determine the relative association of variables such as strand-
ing, nodularity, and size to this diagnosis. Our hypothesis was
that even experienced observers would be unable to differen-
tiate between lipomas and well-differentiated liposarcomas.
Therefore, if treating physicians were unable to accurately
diagnose these tumors on imaging or via biopsy, an argument
suggesting that all symptomatic low-grade fatty lesions may
be treated with marginal excision could be supported. While
the results presented here are better than chance alone, they
do reaffirm that a definitive diagnosis cannot be made on
imaging alone until better imaging criteria are identified.
We also present data here that supports several other
variables surrounding the radiographic diagnosis of low-
grade fatty lesions. First, there is a substantial interrater
reliability based on kappa statistics towardsmaking the radio-
graphic diagnosis. These data are based on a high number
of readers and the categorical variables of “lipoma” versus
“liposarcoma.” In addition, the relative accuracy of observers
from musculoskeletal radiology and orthopaedic oncology
with various levels of training (fellow versus staff) was not
statistically different. Finally, the variables of size, nodularity,
and stranding did show an association with the diagnosis
of well-differentiated liposarcoma and as such based on
these data should continue to be used in the radiographic
interpretation of these tumors.
Other authors have evaluated the utility of MRI in
the differentiation of well-differentiated liposarcoma from
lipoma and determined the value of fluid-sensitive imaging
sequences in making this distinction [2, 3, 10]. Doyle et al.
evaluated the observer performance using T1-weighted spin
echo and fluid-sensitive MRI sequences [1]. They found sen-
sitivity over 94% for T1-weighted images and 100% for fluid-
sensitive sequences. Specificities however for these same
imaging sequences were 76% and 64% for the T1-weighted
sequences and 70% and 73% for the fluid-sensitive images.
The interobserver agreement was rated as “good” based on
kappa statistics. This study however only had two observers,
both radiologists, and a small representative number of well-
differentiated liposarcomas in the study design (18 of 51
tumors). In addition, these authors attempted to correlate
the radiographic findings with pathological variables like
fibrosis, stranding, andnodularity; however, theywere unable
to make associations between these pathological variables
and the observed radiographic parameters. As such, Doyle
et al. question the diagnostic importance of nodularity,
stranding, and size in the differentiation of lipomas from
well-differentiated liposarcomas on imaging alone. Our data
however suggests that the variables of nodularity, stranding,
and size do show association with the correct radiographic
diagnosis and therefore should continue to be used despite
the poor correlation to pathological variables. One key point
in the differentiation between the presented data and that of
Doyle et al. is that the histological variable of fibrosis may
not correlate with the radiographic viable of stranding. As
those authors did not specifically map this fibrosis within
the pathological specimen to areas specified on the MRI, we
question the validity of the author’s conclusions.
The accuracy of diagnosis presented here (69%) is lower
than that documented in previous reports [1–3]. In one
such report, Gaskin and Helms retrospectively reviewed
126 lesions and determined the sensitivity, specificity, and
accuracy of MRI in making the distinction between lipoma,
lipoma variants, and well-differentiated liposarcoma [10].
They reported an overall accuracy in their study of 83%;
however, there are several differences between that study
and data presented here. Gaskin and Helms selected cases
through a radiological database search by identification of key
phrases (such as “lipo-” or “fat”) in the radiological report.
Only after selection of 126 cases which other radiologists had
been confident enough to use such terms were the patho-
logical diagnoses reviewed. This method of case inclusion
represents a selection bias given the prior documentation by
reading radiologists of the terms “lipo-” or “fat.” Lesions with
concerning heterogeneity, nodularity, or stranding in which
the MRI evaluation suggested a more aggressive diagnosis
than a lipomatous or fatty tumor would be excluded using
this method of selection. Given the heterogeneity of fatty
tumors and the fact that the pathological diagnosis is the
most valid, our presented accuracy may be appropriate.
The second difference between the study by Gaskin and
Helms was that only 64 of 126 tumors were resected at their
tertiary institution and available for review by their trained
musculoskeletal pathologist. Again, given the heterogeneity
within the diagnosis of well-differentiated liposarcoma and
the specific diagnostic criteria surrounding this diagnosis, the
presented radiological accuracy in that studymay not be truly
representative of all low-grade fatty lesions [9].
Data presented here suggests that the variables of size,
nodularity, and stranding show an association with the
ultimate pathological diagnosis and as such should continue
to be used in the radiographic interpretation [2]. It has been
our experience that size is the variable most often used
by referral centers or radiologists to suggest a diagnosis of
well-differentiated liposarcoma but the variable least used by
our treatment team in making the ultimate decision a MRI
diagnosis. Obviously size does matter given the association
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between concerning size and the pathological diagnosis of
well-differentiated liposarcoma [2]. While the association of
size to the diagnosis of well-differentiated liposarcoma was
not as strong as the variables of stranding and nodularity
(Figures 3 and 4), all these represent variables that need
to be considered when rendering an ultimate radiographic
impression.
Recently, the identification and gene amplification of
the MDM2 gene have been identified to supplement the
pathological diagnosis of liposarcoma [14, 15]. Unfortunately,
the majority of the patients utilized in this study did not
have MDM2 FISH for the pathological diagnosis. For the
majority of patients in this study, the pathological analysis
and diagnosis were made without usage of MDM2 gene
amplification. This represents a limitation to this study. For
this study, pathological review and diagnosis were made
by one of three pathologists with subspeciality training in
musculoskeletal oncology and sarcoma pathology following
WHO criteria for the classification of sarcoma.
At tertiary referral sarcoma centers, where the treatment
teamunderstands the lowmetastatic potential of these lesions
and the appropriateness of a marginal excision, the inability
to differentiate these lesions onMRI alone does not represent
a major treatment dilemma, as symptomatic tumors require
marginal excision without adjuvant treatment [5, 6, 16].
On the contrary, at smaller centers with less experience in
musculoskeletal oncology or the specific biology of well-
differentiated liposarcoma, statements such as “liposarcoma
cannot be excluded,” or “referral to sarcoma center is nec-
essary,” are all too common. Phrases such as these lead to
patient worry and unnecessary referral. It has been proposed
to characterize all such lesions as “low-grade fatty tumors”
which at worst represent well-differentiated liposarcomas.
Then, with an understanding of the low metastatic risk and
appropriatemanagement of these tumors, treating physicians
could more appropriately counsel patients and avoid unnec-
essary referral.
5. Conclusion
Experienced observers in musculoskeletal radiology and
orthopaedic oncology can differentiate between lipomas and
well-differentiated liposarcomas in 69% of cases. This level
of accuracy needs to be improved upon with accepted and
validated mechanisms to differentiate between these two
entities. The variables of nodularity, stranding, and relative
size do show an association with the diagnosis of well-
differentiated liposarcoma and therefore should continue to
be used in the radiographic impression. A better under-
standing of the biology of well-differentiated liposarcomas,
appropriate treatment, and risk of local recurrence/overall
survival related to this diagnosis is important to appropriately
counsel patients and avoid unnecessary referral.
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